Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AntiPlatelet theraPy stratEgy followiNg left atrial appenDAGe closurE (APPENDAGE)
2020-004263-84Phase 2Active
- Sponsor
- Centre Hospitalier Universitaire de Bordeaux
- Start
- Oct 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in Atrial fibrillation (AFib), ischemic stroke and thromboembolism comparing Aspirin monotherapy with Aspirin + clopidogrel (2 arms). Primary endpoint: Number of new ischemic brain lesions on MRI between immediate post‑procedure and 3 months. Started Oct 2020; status: active.
02
Drugs
aspirinclopidogrel
03
Conditions
Atrial fibrillation (AFib)ischemic strokethromboembolism
Beyond the preview
Go deeper on 2020-004263-84.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004263-84.